Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Sensitisation data (human)

Currently viewing:

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
01 January 1990 to 31 December 1994
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Well performed study under good scientific standards

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1998
Report date:
1997

Materials and methods

Type of sensitisation studied:
skin
Study type:
study with volunteers
Test guideline
Qualifier:
no guideline followed
GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Grotan OD, Reaction product from paraformaldehyde and 2 hydroxypropylamine (ratio of 3:2)
IUPAC Name:
Grotan OD, Reaction product from paraformaldehyde and 2 hydroxypropylamine (ratio of 3:2)
Details on test material:
- Name of test material (as cited in study report): Grotan OD
- Chemical name: Methylene-bis-(methyloxazolidine)
- Substance type: Formaldehyde releaser
- Physical state: Liquid
- Composition of test material, percentage of components: Reaction product from paraformaldehyde and 2 hydroxypropylamine (ratio of 3:2)

Method

Type of population:
occupational
Ethical approval:
not specified
Subjects:
- Number of subjects exposed: 1787 patients were patch tested in an industrial biocide tray

Occupation (only most frequent)
20% mechanics, toolmakers, engineers
14% metal workers
4% office workers
3% electricians
8% undetermined exposure

- Sex: 76% male patients and 24% female patients
- Age: 55% < 40 years, 45% > 40 years

Clinical history:
- History of allergy or casuistics for study subject or populations: Continously recorded for all patients
- Symptoms, onset and progress of the disease: Atopic dermatitis past or present 21%; allergic rhinoconjunctivitis 11%; allergic bronchial asthma 5%;occupational causes suspected in 46%; Localization of contact dermatitis mostly hands (65%)

- Exposure history: Occupational history and suspected allergen exposure continously recorded
Route of administration:
dermal
Details on study design:
TYPE OF TEST(S) USED: Epicutaneous patch tests; patients exposed to the test substance for 24 or 48 h (most patients 48 h); Patch test performed according to recommendations of the International Contact Dermatitis Research Group; in most hospitals investigators used “Finn-chambers-on Scanpor” method (no further details); reaction were scored 72 h after application of chambers. Test item concentartion 1% in PET (Petrolatum).
No further data available.

Results and discussion

Results of examinations:
NO. OF PERSONS WITH/OUT REACTIONS COMPARED TO STUDY POPULATION
46 out of 1522 tested patients (3.0%) showed an allergic reaction after exposure to the substance “reaction product from paraformaldehyde and 2-hydroxypropylamine (ratio 3:2)”, 19 patient showed a questionable/irritative reaction. The age-adjusted frequency of sensitization in men was 2.3% at <40 years and 4.6% at >40 years.

Applicant's summary and conclusion

Conclusions:
Some evidence for sensitizing activity in humans. Numerous industrial biocides were tested in this study. The substance has been shown to be one of the most sensitizing substances.
Executive summary:

The available data give some information about the sensitizing potential of the test substance after occupational use.. Epicutaneous patch tests: patients exposed to the test substance for 24 or 48 h (most patients 48 h); reaction were scored 72 h after application of chambers. 1522 patients were tested with the test substance.

In a group of 1522 patients tested for contact allergy 46 patients (or 3.0%) showed a positive reaction after exposure to the substance. Similar results were presented by Geier et al., 1997.